OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
3.800
-0.080 (-2.06%)
At close: Feb 21, 2025, 4:00 PM
3.830
+0.030 (0.79%)
After-hours: Feb 21, 2025, 7:56 PM EST
OraSure Technologies Revenue
OraSure Technologies had revenue of $39.92M in the quarter ending September 30, 2024, a decrease of -55.25%. This brings the company's revenue in the last twelve months to $224.26M, down -50.46% year-over-year. In the year 2023, OraSure Technologies had annual revenue of $405.47M with 4.64% growth.
Revenue (ttm)
$224.26M
Revenue Growth
-50.46%
P/S Ratio
1.26
Revenue / Employee
$351,509
Employees
638
Market Cap
283.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 405.47M | 17.99M | 4.64% |
Dec 31, 2022 | 387.48M | 153.81M | 65.82% |
Dec 31, 2021 | 233.67M | 61.95M | 36.08% |
Dec 31, 2020 | 171.72M | 17.12M | 11.07% |
Dec 31, 2019 | 154.61M | -27.14M | -14.93% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OSUR News
- 9 days ago - OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th - GlobeNewsWire
- 5 weeks ago - NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims - Business Wire
- 6 weeks ago - OraSure to Present at the J.P Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewsWire
- 6 weeks ago - OraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewsWire
- 2 months ago - OraSure Technologies Acquires Sherlock Biosciences - GlobeNewsWire
- 2 months ago - OraSure Technologies: Discounted Assets With An Attractive Free Call Option - Seeking Alpha
- 2 months ago - OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test - GlobeNewsWire